Literature DB >> 11837638

Limited immune reconstitution at intermediate stages of HIV-1 infection during one year of highly active antiretroviral therapy in antiretroviral-naive versus non-naive adults.

M Martín1, S Echevarría, F Leyva-Cobián, I Pereda, M López-Hoyos.   

Abstract

Although several reports have attributed the clinical benefits of highly active antiretroviral therapy (HAART) to a possible immune restoration, long-term data are still scarce and most derive from patients with either advanced or very early stages of HIV infection. In the present study, changes in lymphocyte subsets, activation markers, and adhesion molecules in CD4+ and CD8+ lymphocytes were carefully monitored over a 1-year period in 27 HIV-infected adults at an intermediate stage of HIV infection. Cytokine-producing patterns were also studied. In these patients the HIV viral load disappeared by month 4 of HAART. Only limited immunological changes were observed: an incomplete recovery of naive CD4+ T cells, a less activated state of CD8+ T cells, and a repopulation of IL-2- and IFN-gamma-producing CD4+ T cells. These changes were observed principally in patients with more advanced disease. Furthermore, HIV-infected subjects who had received HAART previously showed less marked immunological changes than antiretroviral-naive individuals. In conclusion, the sustained viral suppression during 1 year of HAART was accompanied by limited immunological recovery at intermediate stages of HIV infection. This finding indicates a need for longer HIV suppression in order to achieve effective recovery of the immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11837638     DOI: 10.1007/s100960100631

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

1.  Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.

Authors:  P Ondoa; S Koblavi-Dème; M-Y Borget; M L Nolan; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

2.  Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution.

Authors:  Ming Zeng; Mirko Paiardini; Jessica C Engram; Greg J Beilman; Jeffrey G Chipman; Timothy W Schacker; Guido Silvestri; Ashley T Haase
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

Review 3.  The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche.

Authors:  Jacob D Estes; Ashley T Haase; Timothy W Schacker
Journal:  Semin Immunol       Date:  2008-07-02       Impact factor: 11.130

4.  Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.

Authors:  Timothy W Schacker; Phuong L Nguyen; Gregory J Beilman; Steven Wolinsky; Matthew Larson; Cavan Reilly; Ashley T Haase
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.

Authors:  Jennifer M Babik; Mark Holodniy
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy.

Authors:  Ming Zeng; Peter J Southern; Cavan S Reilly; Greg J Beilman; Jeffrey G Chipman; Timothy W Schacker; Ashley T Haase
Journal:  PLoS Pathog       Date:  2012-01-05       Impact factor: 6.823

7.  Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Authors:  Odin Goovaerts; Wim Jennes; Marguerite Massinga-Loembé; Pascale Ondoa; Ann Ceulemans; Chris Vereecken; William Worodria; Harriet Mayanja-Kizza; Robert Colebunders; Luc Kestens
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 8.  Lymphoid Tissue Mesenchymal Stromal Cells in Development and Tissue Remodeling.

Authors:  Luca Genovese; Andrea Brendolan
Journal:  Stem Cells Int       Date:  2016-04-13       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.